Literature DB >> 26667723

SUITABILITY OF VISCERAL ADIPOSITY INDEX AS A MARKER FOR CARDIOMETABOLIC RISKS IN JORDANIAN ADULTS.

Mousa Numan Ahmad1, Fares Halim Haddad2.   

Abstract

INTRODUCTION: visceral adiposity index (VAI) has recently been proposed as a predictor of cardiometabolic risk, but its usefulness has not been confirmed.
OBJECTIVES: to evaluate the association between VAI and conventional adiposity and cardiometabolic risk indices and examine VAI risk predictive ability and compare it with other adiposity indices.
METHODS: a total of 1 622 Jordanian adults, 686 men and 936 women, aged 20-80 years were included this study. VAI, body mass index (BMI), waist circumference (WC), waist-hip ratio (WHR), waist-height ratio (WHtR) were examined and high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting serum glucose (FSG), systolic (SBP), and diastolic (DBP) blood pressure were determined. Associations and age-and gender specific distribution and differences were evaluated. Receiver operating characteristic (ROC) curve and area under curve (AUC) were used for risk predictive ability comparison.
RESULTS: VAI of women (6.82±6.43) was higher than of men (4.15±4.62). VAI severity increased with age in a dose-response trend (p<0.001) in both genders. Women had higher prevalence than men of high risks of VAI and all adiposity and cardiometabolic indices. VAI markedly associated with TG, HDL-C, FSG, SBP and DBP or WHR, WC, WHtR and BMI in respective order of correlation potency for cardiometabolic or adiposity risk indices. In men and women respectively, the largest AUC was for VAI (0.79 vs. 0.77), followed by WHR (0.73 vs. 0.75), WC (0.69 vs. 0.74), WHtR (0.65 vs. 0.71) and BMI (0.53 vs. 0.51).
CONCLUSIONS: the findings suggest that VAI potentially associates with cardiometabolic risks and proves to be superior to other adiposity indices in predicting such risk. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26667723     DOI: 10.3305/nh.2015.32.6.9543

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  7 in total

1.  Association of Wrist Circumference and Waist-to-Height Ratio with Cardiometabolic Risk Factors among Type II Diabetics in a Ghanaian Population.

Authors:  Christian Obirikorang; Yaa Obirikorang; Emmanuel Acheampong; Enoch Odame Anto; Emmanuel Toboh; Evans Adu Asamoah; Bright Amakwaa; Emmanuella Nsenbah Batu; Peter Brenya
Journal:  J Diabetes Res       Date:  2018-02-19       Impact factor: 4.011

2.  Non-Invasive Prediction of Coronary Artery Disease by Multiple Abdominal Fat and Anthropometric Indices: Revisit.

Authors:  Mohammed Hazem; Mohamed Ezzat; Mahmoud Elsamman; Abdulwahab AlYahya; Mohamad Hasan Alam-Eldeen
Journal:  Int J Gen Med       Date:  2021-02-09

3.  Visceral adiposity index performed better than traditional adiposity indicators in predicting unhealthy metabolic phenotype among Chinese children and adolescents.

Authors:  Yangyang Dong; Ling Bai; Rongrong Cai; Jinyu Zhou; Wenqing Ding
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

4.  Visceral Adiposity Index Is a Measure of the Likelihood of Developing Depression Among Adults in the United States.

Authors:  Jun Lei; Yaoyue Luo; Yude Xie; Xiaoju Wang
Journal:  Front Psychol       Date:  2022-03-25

5.  Visceral adiposity index and sex differences in relation to peripheral artery disease in normal-weight adults with hypertension.

Authors:  Yumeng Shi; Chao Yu; Lihua Hu; Minghui Li; Wei Zhou; Tao Wang; Lingjuan Zhu; Huihui Bao; Ping Li; Xiaoshu Cheng
Journal:  Biol Sex Differ       Date:  2022-05-12       Impact factor: 8.811

6.  Visceral Obesity in Non-Small Cell Lung Cancer.

Authors:  Lindsay Nitsche; Yeshwanth Vedire; Eric Kannisto; Xiaolong Wang; Robert J Seager; Sarabjot Pabla; Santosh K Patnaik; Sai Yendamuri
Journal:  Cancers (Basel)       Date:  2022-07-15       Impact factor: 6.575

7.  Effect of Gum Arabic (Acacia Senegal) supplementation on visceral adiposity index (VAI) and blood pressure in patients with type 2 diabetes mellitus as indicators of cardiovascular disease (CVD): a randomized and placebo-controlled clinical trial.

Authors:  Rasha Babiker; Khalifa Elmusharaf; Michael B Keogh; Amal M Saeed
Journal:  Lipids Health Dis       Date:  2018-03-20       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.